DOvEE - Diagnosing Ovarian & Endometrial Cancer Early
Diagnosing Ovarian & Endometrial Cancer Early (DOvEE) by Targeting Symptomatic Women
McGill University
13,600 participants
Jan 1, 2012
OBSERVATIONAL
Conditions
Summary
This study hopes to improve early detection of ovarian and endometrial cancers. It will determine if women with bloating, abdominal distension, abdominal/pelvic pain, increased urinary frequency and/or early satiety, benefit from earlier surgery after screening by CA-125 ovarian cancer biomarker and transvaginal ultrasound.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
* CA-125 biomarker blood test at visit 1, day 1. * CA-125 biomarker blood test at visit 2, week 6.
-Transvaginal Ultrasound at visit 1, day 1.
Phone call 6 months after last visit to verify continued health.
Locations(8)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02296307